Search Instructions:
* Filter the ENTIRE resource library: Choose a Subject OR a Type of Item at the bottom of the page from the buttons to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (195 total)
- Subject is exactly "Treatment & Care"
Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of CASIRIVIMAB and IMDEVIMAB
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-11-21
Description: Casirivimab and imdevimab to be administered together for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct…
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-11-21
Description: Casirivimab and imdevimab to be administered together for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct…
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19
Creator: Infectious Diseases Society of America (IDSA)
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-11-22
Description: These are regularly updated guidelines on the treatment and management of patients with COVID-19.
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-11-22
Description: These are regularly updated guidelines on the treatment and management of patients with COVID-19.
Covid-19–Associated Myopathy Caused by Type I Interferonopathy
Creator: Manzano, Giovanna S., Jared K. Woods, and Anthony A. Amato.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2020-11-20
Description: The syndrome of Covid-19 infection includes myalgias and elevated creatine kinase levels in at least a third of patients. Whether the elevation in creatine kinase level is caused by viral infection of muscle, toxic effects of cytokines, or another…
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2020-11-20
Description: The syndrome of Covid-19 infection includes myalgias and elevated creatine kinase levels in at least a third of patients. Whether the elevation in creatine kinase level is caused by viral infection of muscle, toxic effects of cytokines, or another…
NETEC COVID-19 Webinar Series (11/25/20): Monoclonal Antibody Therapeutics: How to Operationalize mAB Therapy at Your Facility
Creator: NETEC
Subject: Treatment & Care
Item Type: Webinar
Date Last Updated: 2020-11-25
Description: In this webinar, we will identify important considerations involving Monoclonal Antibody Therapeutics available for emergency use authorization (EUAs) for mild-to-moderate COVID-19 cases, discuss recent criteria for the FDA approved investigational…
Subject: Treatment & Care
Item Type: Webinar
Date Last Updated: 2020-11-25
Description: In this webinar, we will identify important considerations involving Monoclonal Antibody Therapeutics available for emergency use authorization (EUAs) for mild-to-moderate COVID-19 cases, discuss recent criteria for the FDA approved investigational…
Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of BARICITINIB
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-11-19
Description: EUA: For emergency use by healthcare providers for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalized adults and pediatric patients 2 years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or…
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-11-19
Description: EUA: For emergency use by healthcare providers for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalized adults and pediatric patients 2 years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or…
Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of multiFiltrate PRO System and multiBic/multiPlus Solutions during the COVID-19 Pandemic
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-04-30
Description: EUA: To provide continuous renal replacement therapy (CRRT) to treat patients in an acute care environment during the COVID-19 pandemic.
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-04-30
Description: EUA: To provide continuous renal replacement therapy (CRRT) to treat patients in an acute care environment during the COVID-19 pandemic.
Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of VEKLURY® (remdesivir) for Hospitalized Pediatric Patients weighing 3.5 kg to less than 40 kg OR Hospitalized Pediatric Patients less than 12 years of age weighing at least 3.5 kg.
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-05-01
Description: EUA: For emergency use by licensed healthcare providers for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalized pediatric patients weighing 3.5 kg to less than 40 kg or hospitalized pediatric patients less than 12 years of age…
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-05-01
Description: EUA: For emergency use by licensed healthcare providers for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalized pediatric patients weighing 3.5 kg to less than 40 kg or hospitalized pediatric patients less than 12 years of age…
Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of FRESENIUS PROPOVEN 2% Emulsion
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-05-08
Description: EUA: To maintain sedation via continuous infusion in patients older than age 16 with suspected or confirmed COVID-19 who require mechanical ventilation in an ICU setting 2
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-05-08
Description: EUA: To maintain sedation via continuous infusion in patients older than age 16 with suspected or confirmed COVID-19 who require mechanical ventilation in an ICU setting 2
Fact Sheet for Healthcare Providers: REGIOCIT (Sodium Chloride and Sodium Citrate Renal Replacement and Regional Anticoagulant solution)
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-08-13
Description: EUA: To be used as a replacement solution only in adult patients treated with continuous renal replacement therapy (CRRT), and for whom regional citrate anticoagulation is appropriate, in a critical care settingFor continuous renal replacement…
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-08-13
Description: EUA: To be used as a replacement solution only in adult patients treated with continuous renal replacement therapy (CRRT), and for whom regional citrate anticoagulation is appropriate, in a critical care settingFor continuous renal replacement…
Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of COVID-19 Convalescent Plasma for Treatment of COVID-19 in Hospitalized Patients
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-08-23
Description: Fact sheet for Convalescent PlasmaEUA: For the treatment of hospitalized patients with Coronavirus Disease 2019 (COVID-19)
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-08-23
Description: Fact sheet for Convalescent PlasmaEUA: For the treatment of hospitalized patients with Coronavirus Disease 2019 (COVID-19)